Godavari Drugs Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 765253,
    "name": "Godavari Drugs",
    "stock_name": "Godavari Drugs",
    "full_name": "Godavari Drugs Ltd",
    "name_url": "stocks-analysis/godavari-drugs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "96.80",
    "chg": -0.28,
    "chgp": "-0.29%",
    "dir": -1,
    "prev_price": "97.08",
    "mcapval": "108.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530317,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE362C01012",
    "curr_date": "Sep 02, 03:30 PM",
    "curr_time": "17:31 PM",
    "last_traded_at": "Sep 02, 03:30 PM IST",
    "bse_nse_vol": "14.43 k",
    "exc_status": "Active",
    "traded_date": "Sep 02, 2026",
    "traded_date_str": "2026 09 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/godavari-drugs-765253-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Godavari Drugs Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/godavari-drugs-ltd-is-rated-sell-4165834",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GodavariDrugsLt_mojoScore_4165834.png",
        "date": "2026-08-23 10:10:40",
        "description": "Godavari Drugs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 09 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Godavari Drugs Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/godavari-drugs-ltd-valuation-shifts-signal-renewed-price-attractiveness-4156999",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GodavariDrugsLt_valuationdot_4156999.png",
        "date": "2026-08-17 08:01:35",
        "description": "Godavari Drugs Ltd has witnessed a significant shift in its valuation parameters, moving from an attractive to a very attractive rating, despite ongoing challenges in the Pharmaceuticals & Biotechnology sector. This revaluation comes amid a backdrop of mixed returns relative to the Sensex and a micro-cap market capitalisation, prompting investors to reassess the stock’s price attractiveness in comparison to its peers."
      },
      {
        "title": "Godavari Drugs Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/godavari-drugs-ltd-is-rated-sell-by-marketsmojo-4149987",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GodavariDrugsLt_mojoScore_4149987.png",
        "date": "2026-08-12 10:11:51",
        "description": "Godavari Drugs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 09 July 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 12 August 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "When is the next results date for Godavari Drugs Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-godavari-drugs-ltd-4148724",
        "imagepath": "",
        "date": "2026-08-11 23:17:21",
        "description": "The next results date for Godavari Drugs Ltd is scheduled for 14 August 2026...."
      },
      {
        "title": "Godavari Drugs Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/godavari-drugs-ltd-is-rated-sell-4131125",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GodavariDrugsLt_mojoScore_4131125.png",
        "date": "2026-08-01 10:10:36",
        "description": "Godavari Drugs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 August 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Godavari Drugs Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/godavari-drugs-ltd-is-rated-sell-4112341",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GodavariDrugsLt_mojoScore_4112341.png",
        "date": "2026-07-21 10:11:16",
        "description": "Godavari Drugs Ltd is rated Sell by MarketsMOJO. This rating was last updated on 09 July 2026, reflecting a change from the previous Hold rating. However, the analysis and financial metrics discussed below represent the stock’s current position as of 21 July 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Godavari Drugs Ltd Downgraded to Sell Amid Mixed Fundamentals and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/godavari-drugs-ltd-downgraded-to-sell-amid-mixed-fundamentals-and-technical-signals-4095852",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GodavariDrugsLt_mojoScore_4095852.png",
        "date": "2026-07-10 08:05:43",
        "description": "Godavari Drugs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 9 July 2026. This decision follows a comprehensive reassessment across four critical parameters: quality, valuation, financial trend, and technicals. Despite delivering market-beating returns over the past year, the company’s deteriorating fundamentals and mixed technical signals have prompted a cautious stance from analysts."
      },
      {
        "title": "Godavari Drugs Ltd Upgraded to Hold on Technical Improvements and Valuation Appeal",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/godavari-drugs-ltd-upgraded-to-hold-on-technical-improvements-and-valuation-appeal-4090116",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GodavariDrugsLt_mojoScore_4090116.png",
        "date": "2026-07-06 08:04:55",
        "description": "Godavari Drugs Ltd has seen its investment rating upgraded from Sell to Hold as of 3 July 2026, reflecting a notable improvement in its technical indicators and valuation metrics despite flat recent financial performance. The pharmaceutical company’s stock has outperformed the broader market over the past year, prompting a reassessment of its prospects across quality, valuation, financial trend, and technical parameters."
      },
      {
        "title": "Godavari Drugs Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/godavari-drugs-ltd-downgraded-to-sell-amid-mixed-financial-and-technical-signals-4068333",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GodavariDrugsLt_mojoScore_4068333.png",
        "date": "2026-06-23 08:17:24",
        "description": "Godavari Drugs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 22 June 2026. This change reflects a complex interplay of technical indicators, valuation metrics, financial trends, and quality assessments that collectively signal caution for investors despite some market-beating returns over the past year."
      }
    ],
    "total": 194,
    "sid": "765253",
    "stock_news_url": "https://www.marketsmojo.com/news/godavari-drugs-765253"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 31.08.2026 - Alteration Of The Main Objects Clause III(A) Of The Memorandum Of Association And Approval Of Revised Notice Of The 38Th Annual General Meeting",
      "datetime": "31-Aug-2026",
      "details": "Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 we inform that the Board of Directors at its meeting held on 31st August 2026 approved the following:",
      "source": "BSE"
    },
    {
      "caption": "Submission Of Statement On Deviation Or Variation In Utilisation Of Funds For The Quarter Ended 30 June 2026",
      "datetime": "17-Aug-2026",
      "details": "Submission of Statement on Deviation or Variation in uitilisation of Funds for the quarter ended 30 june 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "17-Aug-2026",
      "details": "Newspaper Publication of Unaudited Results for quarter ended 30.06.2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Godavari Drugs Ltd is Rated Sell

2026-08-23 10:10:40

Godavari Drugs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 09 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Godavari Drugs Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-08-17 08:01:35

Godavari Drugs Ltd has witnessed a significant shift in its valuation parameters, moving from an attractive to a very attractive rating, despite ongoing challenges in the Pharmaceuticals & Biotechnology sector. This revaluation comes amid a backdrop of mixed returns relative to the Sensex and a micro-cap market capitalisation, prompting investors to reassess the stock’s price attractiveness in comparison to its peers.

Read full news article

Godavari Drugs Ltd is Rated Sell by MarketsMOJO

2026-08-12 10:11:51

Godavari Drugs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 09 July 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 12 August 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

When is the next results date for Godavari Drugs Ltd?

2026-08-11 23:17:21

The next results date for Godavari Drugs Ltd is scheduled for 14 August 2026....

Read full news article

Godavari Drugs Ltd is Rated Sell

2026-08-01 10:10:36

Godavari Drugs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 August 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Godavari Drugs Ltd is Rated Sell

2026-07-21 10:11:16

Godavari Drugs Ltd is rated Sell by MarketsMOJO. This rating was last updated on 09 July 2026, reflecting a change from the previous Hold rating. However, the analysis and financial metrics discussed below represent the stock’s current position as of 21 July 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Godavari Drugs Ltd Downgraded to Sell Amid Mixed Fundamentals and Technical Signals

2026-07-10 08:05:43

Godavari Drugs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 9 July 2026. This decision follows a comprehensive reassessment across four critical parameters: quality, valuation, financial trend, and technicals. Despite delivering market-beating returns over the past year, the company’s deteriorating fundamentals and mixed technical signals have prompted a cautious stance from analysts.

Read full news article

Godavari Drugs Ltd Upgraded to Hold on Technical Improvements and Valuation Appeal

2026-07-06 08:04:55

Godavari Drugs Ltd has seen its investment rating upgraded from Sell to Hold as of 3 July 2026, reflecting a notable improvement in its technical indicators and valuation metrics despite flat recent financial performance. The pharmaceutical company’s stock has outperformed the broader market over the past year, prompting a reassessment of its prospects across quality, valuation, financial trend, and technical parameters.

Read full news article

Godavari Drugs Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals

2026-06-23 08:17:24

Godavari Drugs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 22 June 2026. This change reflects a complex interplay of technical indicators, valuation metrics, financial trends, and quality assessments that collectively signal caution for investors despite some market-beating returns over the past year.

Read full news article

View All News